Knockdown of VGLUT1 results in a concomitant decrease in synaptic expression of synapsin and synaptophysin. by Corbett T. Berry (296520)

“…(<b>E</b>) Synaptophysin was not decreased in KD neurons co-expressing VGLUT1 (<i>V1</i>, VGLUT1 expressing neurons; p = 0.940; n = 244 and 96 puncta from 13 and 9 axons for SCR and V1, respectively, from a representative experiment. …”

Decrease of myopia progression with 0.025% atropine by Celso Marcelo da Cunha (4894324)

“…Paired student’s t-test was used to compare refractions, axial length and keratometry which were measured in an initial exam and after a two-year follow-up. Results: Of the 60 children, the 30 in group 1 had an age mean and SD 8.21 +/- 1.72, and of the control group were 8.17 +/- 1.73 years. …”

Calyculin A-induced decrease of tyrosine-monophosphorylated ERK2 at high cell density. by Noriyuki Kawabata (3391739)

Decrease in the frequency of FGF-2/EGF addition increases cell death in aOBSCs. by Vanesa Nieto-Estévez (107326)

“…Graphs show the percentage of cells in each group (<b>D</b>, E13.5 OBSCs; <b>H</b>, aOBSCs). The results represent the mean ± SEM from 3–5 passages from 2 different cell cultures per condition. …”

Decrease in CLPs, NKPS and Block in NKP progression. by John Richards (53768)

Silencing of TET3 acted to decrease mitochondrial respiration in N2A cells. by Valeria Leon Kropf (17797623)

MES transiently decreases mitochondrial membrane potential. by Shingo Matsuyama (672132)

Multiple miRNAs decrease telomerase activity. by Radmila Hrdličková (523455)

Decrease of ERK phosphorylation by NOS inhibitor TRIM. by Immacolata Castellano (603814)

A blue-shifted fluorescence donor increases fAP amplitude but exhibits a decreased SNR. A. by Ann E. Fink (312543)

GSH content was decreased in low glucose conditions. by Martine Emery (215947)

Dopamine decreases the refractive power in the lens periphery. by J. Marcus Schartau (365288)

“…<p>(A) The mean ΔBCD curves describe the difference between the treated and untreated lenses from all animals (see <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0010402#s4" target="_blank">Methods and Materials</a>). …”

B2 decreases glycolytic intermediates in cells. by Craig Eyster (392633)

“…<b>(C)</b> Heatmap of targeted metabolomic data. Each column is a separate biological replicate (n = 5). The box indicates the clustering of decreased downstream glycolytic intermediates in B2-treated cells. …”

Effects of decreased cellulose on cell wall thickness. by Takumi Higaki (87635)

“…<p>(a) Transmission electron microscopic images of the cotyledon lateral cell wall in an <i>rsw2/kor1</i> mutant, in which cellulose production is decreased. …”

Fucoidan decreased lung metastases of breast cancer. by Meilan Xue (310911)

Laquinimod prevents EAE and decreases encephalitogenicity of T cells. by Ulf Schulze-Topphoff (174453)

“…Representative FACS staining is shown including quantification (n = 4–5 mice per group). (E) Laquinimod decreases pathogenic potential of T cells. …”

Erlotinib decreases hypoxia <i>in vivo</i>. by George J. Cerniglia (261405)

Klotho decreased the expression of CHOP in mouse heart. by Shuang Song (457799)

Madrasin decreases transcription of protein-coding genes. by Michael Tellier (8284752)

MBCD decreased stemness in MDA-MB-231. by Ankit Sharma (578833)

“…<p>(<b>A</b>) Colony formation assay was performed. MDA-MB-231 cells were plated at low density (1000 cells/well) in 6 well plates. …”